Beranda › Penyakit Ginjal Kronis › Tennessee › Nashville
Uji klinis Penyakit Ginjal Kronis di Nashville, TN
6 studi untuk Penyakit Ginjal Kronis mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Menerima pesertaFase 3
- Research Site, Nashville
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Menerima pesertaFase 3
- Vanderbilt University Medical Center, Nashville
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Menerima pesertaFase 3
- Knoxville Kidney Center Pllc, Brentwood · 9 mi jauhnya
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Menerima pesertaFase 2
- Vanderbilt University Medical Center, Nashville
Empagliflozin Treatment in Kidney Transplant Recipients
Menerima pesertaFase 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
Menerima peserta
- Vanderbilt University Medical Center, Nashville
Uji klinis Penyakit Ginjal Kronis di kota lain
- New York City, NY17 studi
- Boston, MA15 studi
- Dallas, TX15 studi
- Houston, TX15 studi
- Philadelphia, PA15 studi
- Chicago, IL12 studi
- Orlando, FL11 studi
- Atlanta, GA10 studi
- Durham, NC9 studi
- Kansas City, MO9 studi
- San Antonio, TX8 studi
- Albuquerque, NM8 studi
Studi lain di Nashville
- Kanker Paru Non-Sel Kecil97 studi
- Kanker Payudara81 studi
- Kanker Metastatik70 studi
- Kanker Kolorektal69 studi
- Kanker (semua jenis)65 studi
- Kanker Ovarium49 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Karsinoma Sel Skuamosa Kepala dan Leher39 studi
- Kanker Pankreas39 studi
- Kanker Endometrium38 studi
- Melanoma33 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.